FDA Approved: AKYNZEO — Supplemental Application (Helsinn Therapeutics (U.S.), Inc.)

View source ↗

Summary

FDA approved a supplemental indication for AKYNZEO (fosnetupitant and palonosetron) to prevent chemotherapy-induced nausea and vomiting in patients receiving ce…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Nausea and Vomiting

Drugs mentioned

• Akynzeo (netupitant/palonosetron)

Snippet

SUPPL AP for AKYNZEO (FOSNETUPITANT AND PALONOSETRON)